SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-013681
Filing Date
2024-04-29
Accepted
2024-04-29 16:06:55
Documents
9
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A crvo20240425_def14a.htm DEF 14A 563329
2 a01.jpg GRAPHIC 13074
3 crvo01.jpg GRAPHIC 260782
4 crvo02.jpg GRAPHIC 185553
5 crvo20240425_def14aimg004.jpg GRAPHIC 5741
6 crvo20240425_def14aimg005.jpg GRAPHIC 17268
7 crvo20240425_def14aimg006.jpg GRAPHIC 17387
8 logosm.jpg GRAPHIC 10403
9 logosmr.jpg GRAPHIC 8046
  Complete submission text file 0001437749-24-013681.txt   1279166
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37942 | Film No.: 24890656
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)